Department of Neonatology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
PLoS One. 2013 May 20;8(5):e63069. doi: 10.1371/journal.pone.0063069. Print 2013.
Despite widespread use in sick infants, it is still debated whether vasopressor-inotropes have direct cerebral effects that might affect neurological outcome. We aimed to test direct cerebrovascular effects of three commonly used vasopressor-inotropes (adrenaline, dopamine and noradrenaline) by comparing the responses to those of nonpharmacologically induced increases in blood pressure. We also searched for reasons for a mismatch between the response in perfusion and oxygenation.
Twenty-four piglets had long and short infusions of the three vasopressor-inotropes titrated to raise mean arterial blood pressure (MAP) 10 mmHg in random order. Nonpharmacological increases in MAP were induced by inflation of a balloon in the descending aorta. We measured cerebral oxygenation (near-infrared spectroscopy), perfusion (laser-Doppler), oxygen consumption (co-oximetry of arterial and superior sagittal sinus blood), and microvascular heterogeneity (side stream dark field video microscopy).
Vasopressor-inotropes increased cerebral oxygenation significantly less (p≤0.01) compared to non-pharmacological MAP increases, whereas perfusion was similar. Furthermore, cerebral total hemoglobin concentration increased significantly less during vasopressor-inotrope infusions (p = 0.001). These physiologic responses were identical between the three vasopressor-inotropes (p>0.05). Furthermore, they induced a mild, although insignificant increase in cerebral metabolism and microvascular heterogeneity (p>0.05). Removal of the scalp tissue did not influence the mismatch (p>0.05).
We demonstrated a moderate vasopressor-inotrope induced mismatch between cerebral perfusion and oxygenation. Scalp removal did not affect this mismatch, why vasopressor-inotropes appear to have direct cerebral actions. The statistically nonsignificant increases in cerebral metabolism and/or microvascular heterogeneity may explain the mismatch. Alternatively, it may simply reflect a vasopressor-inotrope-induced decrease in the arterial-to-venous volume ratio as detected by near-infrared spectroscopy.
尽管升压-正性肌力药物在患病婴儿中广泛使用,但它是否具有直接的脑血管作用从而影响神经结局仍存在争议。我们旨在通过比较三种常用的升压-正性肌力药物(肾上腺素、多巴胺和去甲肾上腺素)与非药理学诱导的血压升高引起的反应来测试其直接的脑血管作用。我们还寻找了灌注和氧合反应不匹配的原因。
24 头小猪随机接受三种升压-正性肌力药物的长时和短时输注,将平均动脉血压(MAP)升高 10mmHg。非药理学诱导的 MAP 升高是通过在降主动脉中充气球囊来实现的。我们测量了脑氧合(近红外光谱)、灌注(激光多普勒)、耗氧量(动脉和上矢状窦血的 co-oximetry)和微血管异质性(侧流暗场视频显微镜)。
与非药理学 MAP 升高相比,升压-正性肌力药物显著降低了脑氧合(p≤0.01),而灌注相似。此外,在升压-正性肌力药物输注期间,脑总血红蛋白浓度显著增加(p=0.001)。这三种升压-正性肌力药物之间的生理反应是相同的(p>0.05)。此外,它们引起了轻微但无统计学意义的脑代谢和微血管异质性增加(p>0.05)。去除头皮组织并未影响这种不匹配(p>0.05)。
我们证明了脑灌注和氧合之间存在中度的升压-正性肌力药物不匹配。头皮去除并未影响这种不匹配,表明升压-正性肌力药物具有直接的脑血管作用。脑代谢和/或微血管异质性的统计学上无显著增加可能解释了这种不匹配。或者,它可能仅仅反映了近红外光谱检测到的升压-正性肌力药物诱导的动脉到静脉容积比降低。